# ğŸ“… Daily Report - 2026-01-07

> ä»Šæ—¥ç­›é€‰å‡º **64** æ¡å†…å®¹ï¼Œæ¥è‡ª **2** ä¸ªæ¥æº

<div class="powered-by-top">Powered by <a href="https://kyplus.de">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai">Claude</a></div>

---

## ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“

### ğŸ§¬ æ•°æ®å‰æ²¿

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
PARPæŠ‘åˆ¶å‰‚åœ¨åµå·¢ç™Œä¸­é€šè¿‡æº¶é…¶ä½“åŒºå®¤åŒ–å®ç°å¼‚è´¨æ€§è“„ç§¯ï¼Œæå‡ç–—æ•ˆã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- å…ç–«æ²»ç–—ï¼š9-PAHSAå¢å¼ºTç»†èƒæŠ—è‚¿ç˜¤å…ç–«ï¼›CD8+ Tç»†èƒè¡°è€æœºåˆ¶åŠé¶å‘è°ƒæ§ï¼›è‚ é“IgA Bç»†èƒçš„æ¥æºã€‚
- è‚¿ç˜¤ç ”ç©¶ï¼šDICER1ç»¼åˆå¾çš„è‚¿ç˜¤å‘è‚²å±‚çº§åˆ†æã€‚
- åŸºç¡€ç”Ÿç‰©å­¦ï¼šBRD2åœ¨è½¬å½•èµ·å§‹ä¸­çš„ä½œç”¨ï¼›è„‚è‚ªå› å­è°ƒèŠ‚é›„æ€§å°é¼ è‚è„è½¬å½•ç»„ä¸èƒ½é‡ä»£è°¢ï¼›ç‰›æ—©æœŸèƒšèƒå‘è‚²çš„ç»„è›‹ç™½ä¹³é…¸åŒ–è°ƒæ§ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- ç©ºé—´è½¬å½•ç»„å­¦ï¼ˆSpatial Transcriptomicsï¼‰åœ¨è‚¿ç˜¤å¼‚è´¨æ€§åŠç»„ç»‡ç»“æ„åˆ†æä¸­çš„åº”ç”¨ã€‚
- ATAC-seqã€ChIP-seqã€scRNA-seqç­‰é«˜é€šé‡æµ‹åºæŠ€æœ¯åœ¨åŸºå› è°ƒæ§ã€ç»†èƒå‘½è¿ä¸ç–¾ç—…æœºåˆ¶ç ”ç©¶ä¸­çš„å¹¿æ³›åº”ç”¨ã€‚

### ğŸ§ª åšå®¢æ›´æ–°

> **ä»Šæ—¥ç„¦ç‚¹**ï¼š
RNAæµ‹åºæŠ€æœ¯åœ¨ç²¾å‡†è‚¿ç˜¤å­¦ä¸­å¼€è¾Ÿæ–°æ–¹å‘ï¼Œé€šè¿‡æ£€æµ‹åŸºå› è¡¨è¾¾ã€èåˆåŠåˆ†å­ä¿¡å·ï¼Œå®ç°æ›´ä¸ªä½“åŒ–çš„ç™Œç—‡æ²»ç–—ã€‚

**ä¸»è¦æ–¹å‘**ï¼š
- è‚ é“èŒç¾¤ä¸å¤§è„‘å‘è‚²å’ŒåŠŸèƒ½è°ƒæ§æœºåˆ¶è¢«æ­ç¤ºã€‚
- æ­ç¤ºäº†MCL1è›‹ç™½è°ƒæ§mTORé€šè·¯ï¼Œé©±åŠ¨ç™Œç»†èƒä»£è°¢å’Œç”Ÿå­˜çš„å…¨æ–°æœºåˆ¶ã€‚
- é˜æ˜äº†æ¯›å›Šè¡°è€è¿‡ç¨‹ä¸­çš„ç»†èƒç±»å‹ç‰¹å¼‚æ€§è½¬å½•å˜åŒ–ï¼Œä¸è„±å‘ã€ç™½å‘ç›¸å…³ã€‚

**æŠ€æœ¯äº®ç‚¹**ï¼š
- æ–°å‹ARRP-seqæµ‹åºæ–¹æ³•æ˜¾è‘—æå‡äº†æ£€æµ‹ç™Œç—‡ä¸­ç¨€æœ‰å’Œæ–°å‹åŸºå› èåˆçš„çµæ•åº¦å’Œæˆæœ¬æ•ˆç›Šã€‚
- å•ç»†èƒåŠæ—¶ç©ºæµ‹åºç»˜åˆ¶äº†äººä½“æ¯›å›Šè¡°è€çš„åˆ†å­å›¾è°±ã€‚

---

## ğŸ“š åˆ†ç±»æµè§ˆ

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (58æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰

**1.** â­ **GSE281519 PARPæŠ‘åˆ¶å‰‚çš„æº¶é…¶ä½“éš”ç¦»é©±åŠ¨åµå·¢ç™Œä¸­çš„å¼‚è´¨æ€§ç§¯ç´¯ä»¥æé«˜ç–—æ•ˆ[ç©ºé—´è½¬å½•ç»„å­¦]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€spatialã€spatial transcriptomicsã€transcriptomics
- ğŸ“ **æè¿°**ï¼šContributors : Carmen Ramirez Moncayo ; Restuadi Restuadi ; Louise FetsSeries Type : OtherOrganism : Homo sapiensPARP inhibitors have had a transformative impact in the treatment of high-grade serous ovarian cancer (HGSOC), but resistance remains a clinical hurdle. Increased expression of ABC drug efflux transporters has been identified as a resistance mechanism in patients but whether intracellular concentrations of these drugs is heterogeneous within tumours remains unclear. We developed a patient-derived explant multi-modal imaging pipeline which demonstrated significant cell-intrinsic heterogeneity of PARP inhibitor accumulation, both between patients and within tumours. Spatial transcriptomics revealed enrichment of apoptotic signatures in high-drug compared to low-drug regions, as well as metabolic and ECM-related differences. While some cases demonstrated a clear anticorrelation of PARP inhibitor levels with MDR1(ABCB1), this was not universal. Rucaparib, an intrinsically fluorescent PARP inhibitor accumulates heterogeneously at the single cell-level in established cell lines, and omics approaches revealed that this is driven by lysosomal sequestration, a pattern also observed in patient samples. Perturbation of lysosomal content altered intracellular levels of rucaparib and niraparib and impacted efficacy suggesting that lysosomes act as a drug reservoir to improve drug response.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281519)

**2.** â­ **GSE315178 9-PAHSA è°ƒæ§ TCR-T ç»†èƒå‘½è¿ä»¥å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«åŠ› [ATAC-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€immunityã€T cellã€ATAC-seq
- ğŸ“ **æè¿°**ï¼šContributor : Xiaozhen ZhangSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusWe identify the endogenous lipid 9-PAHSA as a potent enhancer of T cell anti-tumor function and stemness, validated in murine models and a clinical trial. Mechanistically, we identify ICAM2 as a direct surface sensor for 9-PAHSA and delineate a downstream signaling axis whereby the ICAM2-Ezrin-mTORC2 cascade drives FOXO1 O-GlcNAcylation at S318, facilitating its nuclear translocation to enact a stem-like transcriptional program. Translating this discovery, we engineered armored human TCR-T cells with potentiated ICAM2 expression, which achieve superior tumor control through their enhanced intrinsic efficacy and a remarkable ability to ignite a coordinated and durable host anti-tumor immune response. Our work establishes a new paradigm of metabolite-sensing in T cell biology and provides a compelling therapeutic strategy to potentiate cellular immunotherapy for intractable cancers.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315178)

**3.** â­ **GSE310383 å¹´é¾„æ— å…³ä¸”å¯é¶å‘çš„è½¬å½•å› å­ç½‘ç»œè°ƒæ§è¡°è€äººç±» CD8+ T ç»†èƒè¡°è€ [ATAC-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šagingã€T cellã€ATAC-seq
- ğŸ“ **æè¿°**ï¼šContributors : Paolo S Turano ; Elizabeth Akbulut ; Hannah K Dewald ; Themistoklis Vasilopoulos ; Patricia Fitzgerald-Bocarsly ; Utz Herbig ; Ricardo IvÃ¡n MartÃ­nez-ZamudioSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensAging impairs immunity in part through the accumulation of CD8+ T cells with senescence features, including a pro-inflammatory transcriptome and impaired proliferative capacity. Using senescent cell isolation coupled with multiomic profiling, we defined the epigenetic regulation of CD8+ T cell senescence in healthy younger and older humans. We discovered that the transition to senescence was controlled by chromatin state-specific transcription factor (TF) networks whose composition was largely insensitive to donor age. These TF networks mediated widespread enhancer remodeling, causing repression of genes essential for proliferation as well as upregulation of inflammatory and secretory pathways. Inhibition of AP1, KLF5, or RUNX2 modulated the transcriptional output and partially restored the blunted transcriptional response to stimulation of senescent CD8+ T cells. Our data also revealed CD8+ T cell senescence gene signatures predictive of response to CAR-T cell therapy in diffuse large B cell lymphomas. Overall, our study defines the gene regulatory mechanisms of senescence in human CD8+ T cells, provides a resource for the interrogation of CD8+ T cell senescence in disease, highlights TF network perturbation as a viable strategy to manipulate the senescence state of CD8+ T cells, and reveals senescent CD8+ T cell gene signatures as valuable prognostic tools for immunotherapy outcome.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310383)

**4.** â­ **GSE310382 å¹´é¾„æ— å…³ä¸”å¯é¶å‘çš„è½¬å½•å› å­ç½‘ç»œè°ƒæ§è¡°è€äººç±» CD8+ T ç»†èƒè¡°è€ [RNA-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šagingã€T cellã€RNA-seq
- ğŸ“ **æè¿°**ï¼šContributors : Paolo S Turano ; Elizabeth Akbulut ; Hannah K Dewald ; Themistoklis Vasilopoulos ; Patricia Fitzgerald-Bocarsly ; Utz Herbig ; Ricardo IvÃ¡n MartÃ­nez-ZamudioSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAging impairs immunity in part through the accumulation of CD8+ T cells with senescence features, including a pro-inflammatory transcriptome and impaired proliferative capacity. Using senescent cell isolation coupled with multiomic profiling, we defined the epigenetic regulation of CD8+ T cell senescence in healthy younger and older humans. We discovered that the transition to senescence was controlled by chromatin state-specific transcription factor (TF) networks whose composition was largely insensitive to donor age. These TF networks mediated widespread enhancer remodeling, causing repression of genes essential for proliferation as well as upregulation of inflammatory and secretory pathways. Inhibition of AP1, KLF5, or RUNX2 modulated the transcriptional output and partially restored the blunted transcriptional response to stimulation of senescent CD8+ T cells. Our data also revealed CD8+ T cell senescence gene signatures predictive of response to CAR-T cell therapy in diffuse large B cell lymphomas. Overall, our study defines the gene regulatory mechanisms of senescence in human CD8+ T cells, provides a resource for the interrogation of CD8+ T cell senescence in disease, highlights TF network perturbation as a viable strategy to manipulate the senescence state of CD8+ T cells, and reveals senescent CD8+ T cell gene signatures as valuable prognostic tools for immunotherapy outcome.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310382)

**5.** â­ **GSE218539 äººç±»å·¦å¿ƒè€³å’Œè‚ºé™è„‰è¢–çš„ç©ºé—´è½¬å½•ç»„å­¦**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šspatialã€spatial transcriptomicsã€transcriptomics
- ğŸ“ **æè¿°**ï¼šContributors : Han Sun ; Juying Han ; Christine S Moravec ; Toshihiro Okamoto ; Kenneth R McCurry ; A M Gillinov ; Mina K Chung ; Davd R Van Wagoner ; John Barnard ; Jonathan D SmithSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHuman left atrial appendage (LAA) and pulmonary vein (PV) tissues were obtained from unused lung or heart transplant donors. Paired LAA and PV sleeve tissues were obtained from two subjects, and an additional 6 PV samples were obtained from other donors. After tissue sectioning and staining, spatial RNAseq was performed. mRNAs from~1000 to 2500 genes were sequenced in each spatial area. Seurat clustering yielded 15 different clusters. These grossly split into two segregating populations, the left and right sides, with one connecting population. Multiple cells and cell types may reside in each 55 Âµm diameter spatial area. A clear asymmetry of clusters was observed in the PV sections, with less asymmetry in the LAA sections. Cell-type marker genes derived from human LAA single nuclei RNAseq were used to determine the dominant cell types in the 15 different clusters. The left side segregating clusters were enriched in cardiomyocytes, while the right side segregating clusters were enriched for other cell types including fibroblasts, vascular smooth muscle cells, endothelial cells, and adipocytes. Spatial transcriptomics clearly resolved the venous, cardiomyocyte, and epicardial regions of the PV tissues, as well as fibrotic regions in LAAs and PVs. Spatial expression of the AF-associated genes PITX2, SHOX2, and HCN4 was also mapped, confirming higher expression of the cardiac master transcription factor SHOX2 in the PV vs. LAA tissues. Expression of the hyperpolarization-activated ion channel HCN4 was sporadic in both PV and LAA specimens.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218539)

**6.** â­ **GSE284622 æŠ—åŸé€‰æ‹©çš„è‚ é“ IgA ç”± IgG1 ç”Ÿå‘ä¸­å¿ƒ B ç»†èƒäº§ç”Ÿ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šantigenã€gutã€regex:gut(-?microbiome)?
- ğŸ“ **æè¿°**ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284622)

**7.** â­ **GSE284621 æŠ—åŸé€‰æ‹©çš„è‚ é“ IgA ç”± IgG1 ç”Ÿå‘ä¸­å¿ƒ B ç»†èƒ (BCR) äº§ç”Ÿ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šantigenã€gutã€regex:gut(-?microbiome)?
- ğŸ“ **æè¿°**ï¼šContributors : Emily Siniscalco ; Hailong Meng ; Gisela Gabernet ; Stephanie Eisenbarth ; Steven KleinsteinSeries Type : OtherOrganism : Mus musculusDetermine whether IgA B cells are derived from IgE B cells during allergy; understand whether IgE and IgA B cells induced during allergy share clonal relationships in the gut.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284621)

**8.** â­ **GSE284620 æŠ—åŸé€‰æ‹©çš„è‚ é“ IgA ç”± IgG1 ç”Ÿå‘ä¸­å¿ƒ B ç»†èƒ (GEX) äº§ç”Ÿ**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šantigenã€gutã€regex:gut(-?microbiome)?
- ğŸ“ **æè¿°**ï¼šContributors : Emily Siniscalco ; Hailong Meng ; Gisela Gabernet ; Stephanie Eisenbarth ; Steven KleinsteinSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDetermine whether IgA B cells are derived from IgE B cells during allergy; understand whether IgE and IgA B cells induced during allergy share clonal relationships in the gut.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284620)

**9.** â­ **GSE309820 å¯¹ DICER1 ç»¼åˆå¾è°±ç³»å¯è¿½è¸ªå°é¼ æ¨¡å‹çš„ç©ºé—´å•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºè‚¿ç˜¤å‘è‚²å±‚çº§ [RNA-Seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€RNA-seqã€spatial
- ğŸ“ **æè¿°**ï¼šContributors : Felix K Kommoss ; Joyce Zhang ; Branden J Lynch ; Shary Y Chen ; Janine Senz ; Yana Moscovitz ; Lesley A Hill ; Wilder Scott ; Jonathan Bush ; Kenneth Chen ; Andrew Roth ; Andreas von Diemling ; William Foulkes ; Gregg B Morin ; Michael Underhill ; Yemin Wang ; David G HuntsmanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDICER1 syndrome predisposes children and young adults to tumor development across various organs. Most of these cancers are sarcomas, which uniquely express the RNase IIIb domain-deficient form of DICER1 and exhibit histological and molecular similarities regardless of their anatomical origins. To uncover their cellular origin and developmental hierarchy, we established a lineage-traceable genetically engineered mouse model allowing for controlled activation of Dicer1 mutations in Hic1+ mesenchymal stromal cells. This resulted in the development of renal tumors closely mirroring human DICER1 sarcoma histologically and molecularly. Spatial single-cell transcriptomics analysis revealed that a Hic1+Pdgfra+Dpt+Pi16+ fibroblastic progenitor population, corresponding to universal fibroblasts of steady-state kidneys, exhibits the capability to undergo rhabdomyoblastic differentiation or transition into proliferative sarcomatous cells. Investigation of patient samples identified analogous cell states and developmental trajectories. This study uncovers a fibroblastic origin for DICER1 sarcoma and provides a faithful model for future mechanistic and translational investigation.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309820)

**10.** â­ **GSE288990 å¯¹ DICER1 ç»¼åˆå¾è°±ç³»å¯è¿½è¸ªå°é¼ æ¨¡å‹çš„ç©ºé—´å•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºè‚¿ç˜¤å‘è‚²å±‚çº§ [scRNA-seq]**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼štumorã€scRNAã€spatial
- ğŸ“ **æè¿°**ï¼šContributors : Felix K Kommoss ; Joyce Zhang ; Branden J Lynch ; Shary Chen ; Janine Senz ; Yana Moscovitz ; Lesley Hill ; Ross Scott ; Jonathan Bush ; Andrew Roth ; Kenneth Chen ; Gregg Morin ; Andreas von Diemling ; Tully Underhill ; William Foulkes ; David G HuntsmanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDICER1 syndrome predisposes children and young adults to tumor development across various organs. Most of these cancers are sarcomas, which uniquely express the RNase IIIb domain-deficient form of DICER1 and exhibit histological and molecular similarities regardless of their anatomical origins. To uncover their cellular origin and developmental hierarchy, we established a lineage-traceable genetically engineered mouse model allowing for controlled activation of Dicer1 mutations in Hic1+ mesenchymal stromal cells. This resulted in the development of renal tumors closely mirroring human DICER1 sarcoma histologically and molecularly. Spatial single-cell transcriptomics analysis revealed that a Hic1+Pdgfra+Mfap4+ fibroblastic progenitor population, corresponding to perivascular universal fibroblasts of steady-state kidneys, exhibits the capability to undergo rhabdomyoblastic differentiation or transition into proliferative sarcomatous cells. Investigation of patient samples identified analogous cell states and developmental trajectories. This study uncovers a fibroblastic origin for DICER1 sarcoma and provides a faithful model for future mechanistic and translational investigation.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288990)

> ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 48 æ¡å†…å®¹ï¼Œè¯¦è§ [æ–‡æœ«](#æ›´å¤š-æ•°æ®å‰æ²¿)

</div>

</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (6æ¡)</summary>

<div class="details-content" markdown="1">

#### è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨6æ¡ï¼‰

**1.** â­ **å¯æ“ä½œçš„è½¬å½•ç»„â€”â€”å°†RNAæµ‹åºçº³å…¥ç²¾å‡†è‚¿ç˜¤å­¦çš„æ¡†æ¶**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šoncologyã€regex:onco(logy|logist|gene|genic)ã€sequencingã€transcriptome
- ğŸ“ **æè¿°**ï¼šRNA sequencing enables detection of actionable gene expression changes, fusions, and signatures that extend beyond DNA testing, supporting more precise and personalized cancer care...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/the-actionable-transcriptome-a-framework-for-incorporating-rna-sequencing-into-precision-oncology/)

**2.** â­ **æ—¥å¸¸ç”Ÿæ´»ä¸­å¸¸è§çš„åŒ–å­¦ç‰©è´¨æ­£åœ¨æ‚„æ— å£°æ¯åœ°æŸå®³è‚ é“æœ‰ç›ŠèŒç¾¤ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šbacteriaã€regex:bacter(ia|ial|ium)ã€gutã€regex:gut(-?microbiome)?
- ğŸ“ **æè¿°**ï¼šA large study has revealed that dozens of widely used chemicals can damage beneficial gut bacteria. Many of these substances, found in pesticides and everyday industrial products, were never thought to affect living organisms at all. When gut bacteria are stressed by these chemicals, some may also become resistant to antibiotics. The research raises new questions about how chemical exposure could be influencing human health behind the scenes.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/01/260104202815.htm)

**3.** â­ **æ­ç¤ºæ¯›å‘è¡°è€çš„å¥¥ç§˜â€”â€”åŸºäºå•ç»†èƒå’Œæ—¶ç©ºæµ‹åºçš„äººç±»æ¯›å›Šè¡°è€åˆ†å­å›¾è°±**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šagingã€sequencingã€single-cell
- ğŸ“ **æè¿°**ï¼šRNA sequencing reveals cell-typeâ€“specific transcriptional changes in aging human scalp, linking stem cell decline, altered signaling, and inflammatory stress to hair loss and graying...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/unraveling-hair-aging-a-molecular-atlas-of-human-hair-follicle-senescence-drawn-by-single-cell-and-spatiotemporal-sequencing/)

**4.** **ARRP-seqâ€”â€”ä¸€ç§æ–°çš„æµ‹åºæ–¹æ³•ï¼Œå¯æé«˜ç™Œç—‡ä¸­ç½•è§å’Œæ–°å‹åŸºå› èåˆçš„æ£€æµ‹ç‡ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancerã€sequencing
- ğŸ“ **æè¿°**ï¼šRNA sequencing with anchored random reverse primers improves detection of rare and novel gene fusions, enabling more sensitive and cost-effective cancer diagnostics...
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.rna-seqblog.com/arrp-seq-a-new-sequencing-approach-improves-detection-of-rare-and-novel-gene-fusions-in-cancer/)

**5.** **äººç±»æ™ºæ…§çš„ç§˜å¯†ï¼Ÿæˆ–è®¸å°±åœ¨æˆ‘ä»¬çš„ç›´è§‰é‡Œã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šgutã€regex:gut(-?microbiome)?
- ğŸ“ **æè¿°**ï¼šNew research shows gut bacteria can directly influence how the brain develops and functions. When scientists transferred microbes from different primates into mice, the animalsâ€™ brains began to resemble those of the original host species. Microbes from large-brained primates boosted brain energy and learning pathways, while others triggered very different patterns. The results suggest gut microbes may have played a hidden role in shaping the human brainâ€”and could influence mental health.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/01/260105165806.htm)

**6.** **ç§‘å­¦å®¶å‘ç°ä¸€ç§éšè—çš„å¼€å…³ï¼Œå®ƒèƒ½å¸®åŠ©ç™Œç»†èƒå¢æ®–ã€‚**
- âœï¸ **ä½œè€…**ï¼šæœªçŸ¥ä½œè€…
- ğŸ·ï¸ **å…³é”®è¯**ï¼šcancer
- ğŸ“ **æè¿°**ï¼šA protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer metabolism by controlling the powerful mTOR growth pathway, tying survival and energy use together. This insight explains why MCL1-targeting drugs can be effectiveâ€”but also why they sometimes damage the heart. Researchers have now identified a way to reduce that risk, potentially unlocking safer cancer therapies.
- ğŸ”— [æŸ¥çœ‹åŸæ–‡](https://www.sciencedaily.com/releases/2026/01/260104202819.htm)


</div>

</details>

## ğŸ“Š å…³é”®è¯ç»Ÿè®¡

| å…³é”®è¯ | å‡ºç°æ¬¡æ•° |
|--------|----------|
| aging | 10 |
| transcriptome | 7 |
| cancer | 7 |
| T cell | 7 |
| histone | 7 |
| RNA-seq | 6 |
| scRNA | 6 |
| spatial | 5 |
| gut | 5 |
| regex:gut(-?microbiome)? | 5 |
| tumor | 4 |
| metabolic | 4 |
| sequencing | 3 |
| transcriptomics | 3 |
| metabolism | 3 |
| antigen | 3 |
| epigenetic | 3 |
| single-cell | 2 |
| ATAC-seq | 2 |
| immunity | 2 |

---

## ğŸ“ æ›´å¤šå†…å®¹

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (48æ¡)</summary>

<div class="details-content" markdown="1">

- [GSE315024 ç»„è›‹ç™½ä¹³åŒ–é€šè¿‡è°ƒèŠ‚èƒšèƒåŸºå› ç»„æ¿€æ´»æ¥ç»´æŒç‰›æ—©æœŸèƒšèƒå‘è‚² [scRNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315024)
- [GSE285928 ä»å…ç–«å’Œä»£è°¢è§’åº¦è¯„ä»·ç‰›è’¡è‹·ä¿ƒè¿›ç­æ´»ä¼ æŸ“æ€§é€ è¡€å™¨å®˜åæ­»ç—…æ¯’ç–«è‹—çš„åŠŸæ•ˆ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285928)
- [GSE310729 å¹´é¾„æ— å…³ä¸”å¯é¶å‘çš„è½¬å½•å› å­ç½‘ç»œè°ƒæ§è¡°è€äººç±» CD8+ T ç»†èƒè¡°è€ [RNA-seq_RNAi_TFs]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310729)
- [GSE310625 å¹´é¾„æ— å…³ä¸”å¯é¶å‘çš„è½¬å½•å› å­ç½‘ç»œè°ƒæ§è¡°è€äººç±» CD8+ T ç»†èƒè¡°è€ [RNA-seq_inhibitors]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310625)
- [GSE310393 å¹´é¾„æ— å…³ä¸”å¯é¶å‘çš„è½¬å½•å› å­ç½‘ç»œè°ƒæ§è¡°è€äººç±» CD8+ T ç»†èƒè¡°è€ [ATAC-seq_inhibitors]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310393)
- [GSE310384 å¹´é¾„æ— å…³ä¸”å¯é¶å‘çš„è½¬å½•å› å­ç½‘ç»œè°ƒæ§è¡°è€äººç±» CD8+ T ç»†èƒè¡°è€ [CUT&Tag]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310384)
- [GSE305385 è„‚è”ç´ è°ƒèŠ‚é›„æ€§å°é¼ è‚è„æ˜¼å¤œè½¬å½•ç»„å’Œèƒ½é‡ä»£è°¢](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305385)
- [GSE281517 PARPæŠ‘åˆ¶å‰‚çš„æº¶é…¶ä½“éš”ç¦»é©±åŠ¨åµå·¢ç™Œä¸­çš„å¼‚è´¨æ€§ç§¯ç´¯ä»¥æé«˜ç–—æ•ˆ[RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281517)
- [GSE289001 å¯¹ DICER1 ç»¼åˆå¾è°±ç³»å¯è¿½è¸ªå°é¼ æ¨¡å‹çš„ç©ºé—´å•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºè‚¿ç˜¤å‘è‚²å±‚çº§ [Xenium]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289001)
- [GSE315451 è¡€æ¶²è¡¨è§‚é—ä¼ ä¸ç¨³å®šæ€§ä¸äººç±»è¡°è€å’Œç–¾ç—…ç›¸å…³ [MDS_CML]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315451)
- [GSE315367 è¡€æ¶²è¡¨è§‚é—ä¼ ä¸ç¨³å®šæ€§ä¸äººç±»è¡°è€å’Œç–¾ç—…ç›¸å…³ [çºµå‘_AML]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315367)
- [GSE315366 è¡€æ¶²è¡¨è§‚é—ä¼ ä¸ç¨³å®šæ€§ä¸äººç±»è¡°è€å’Œç–¾ç—…ç›¸å…³ [å¿ƒæºæ€§ä¼‘å…‹]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315366)
- [GSE291899 åŒæ°§çœŸèŒå’Œé“¾å»¶é•¿ç»†èŒçš„å…±åŸ¹å…»ç‰©èƒ½ç¨³å®šåœ°å°†æœ¨è´¨çº¤ç»´ç´ è½¬åŒ–ä¸ºä¸é…¸å’Œå·±é…¸](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291899)
- [GSE287728 BRD2 è¿æ¥ TFIID å’Œç»„è›‹ç™½ä¹™é…°åŒ–åœ¨è½¬å½•èµ·å§‹ä¸­çš„ä½œç”¨ [ChIP-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287728)
- [GSE287723 BRD2 è¿æ¥ TFIID å’Œç»„è›‹ç™½ä¹™é…°åŒ–åœ¨è½¬å½•èµ·å§‹ä¸­çš„ä½œç”¨ [RNA-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287723)
- [GSE305091 Tet2 è°ƒèŠ‚ç³–å°¿ç—…ä¸­çš„å†…è´¨ç½‘åº”æ¿€ååº”ã€Î² ç»†èƒæ­»äº¡å’Œè‡ªèº«å…ç–« [scRNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305091)
- [GSE302830 äº”å› å­ï¼ˆM5ï¼‰å¤„ç†å¯¹è§’è´¨å½¢æˆç»†èƒç³»HaCaTè½¬å½•ç»„çš„å½±å“](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302830)
- [GSE296953 PIONEERè¯•éªŒç»“æœï¼šä¸€é¡¹æ—¨åœ¨è¯„ä¼°å­•æ¿€ç´ å—ä½“ï¼ˆPRï¼‰æ¿€åŠ¨å‰‚ç”²åœ°å­•é…®è”åˆæ¥æ›²å”‘æ²»ç–—æ—©æœŸé›Œæ¿€ç´ å—ä½“ï¼ˆERï¼‰é˜³æ€§ä¹³è…ºç™Œçš„â€œæœºä¼šçª—å£â€è¯•éªŒï¼šåˆ©ç”¨ER-PRç›¸äº’ä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296953)
- [GSE295594 é«˜åº¦åŠ¨æ€çš„ç¡¬è„‘è†œçª¦æ”¯æŒè„‘è†œå…ç–«](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295594)
- [GSE291294 é€šè¿‡æ”¹å˜å¹²ç»†èƒ RNA è°ƒæ§æ¥é—ä¼ å¯¹å…‹éš†é€ è¡€çš„æŠµæŠ—åŠ› [scRNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291294)
- [GSE291293 é€šè¿‡æ”¹å˜å¹²ç»†èƒ RNA è°ƒæ§æ¥é—ä¼ å¯¹å…‹éš†é€ è¡€çš„æŠµæŠ—åŠ› [bulk RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291293)
- [GSE283879 ATAD2 é©±åŠ¨ HIRA/ç»„è›‹ç™½ H3.3 ä¾èµ–çš„æŸ“è‰²è´¨åŠ¨åŠ›å­¦](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283879)
- [GSE277943 ATAD2 é©±åŠ¨ HIRA/ç»„è›‹ç™½ H3.3 ä¾èµ–çš„æŸ“è‰²è´¨åŠ¨åŠ›å­¦](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277943)
- [GSE315594 äº¤é…è°ƒèŠ‚é›Œæ€§æœè‡ä¸­è‚ çš„ç”Ÿé•¿ã€ä»£è°¢å’Œæ¶ˆåŒ–æ•ˆç‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315594)
- [GSE311209 æ¯”è¾ƒè½¬å½•ç»„åˆ†ææ­ç¤ºäº†èƒ¸è†œè‚ºæ¯ç»†èƒç˜¤å’Œå…ˆå¤©æ€§è‚ºæ°”é“ç•¸å½¢ II çš„ä¸åŒå‘ç—…æœºåˆ¶](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311209)
- [GSE311205 æ¯”è¾ƒè½¬å½•ç»„åˆ†ææ­ç¤ºäº†èƒ¸è†œè‚ºæ¯ç»†èƒç˜¤å’Œå…ˆå¤©æ€§è‚ºæ°”é“ç•¸å½¢ä¸åŒçš„å‘ç—…æœºåˆ¶ I](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311205)
- [GSE302290 è‚ é“ä¸Šçš®ç»’æ¯›åŒ–ç”±Foxl1é©±åŠ¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302290)
- [GSE292273 MECOMï¼šARé©±åŠ¨çš„è€è¯æ€§å»åŠ¿æŠµæŠ—æ€§å‰åˆ—è…ºç™Œé¢†åŸŸçš„æ–°æˆå‘˜](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292273)
- [GSE225125 æ­£å¸¸å’Œæ¶æ€§æœªæˆç†Ÿ T ç»†èƒä¸­ Zmiz1 ä¾èµ–çš„å¤©ç„¶å¹²ç»†èƒè½¬å½•å›è·¯ [RNA-seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225125)
- [GSE315604 ä¸­æ€§ç²’ç»†èƒå’Œå·¨å™¬ç»†èƒåœ¨æ€¥æ€§è‚ºæŸä¼¤ä¸­é˜¶æ®µç‰¹å¼‚æ€§å…ç–«é‡å¡‘çš„åŠ¨æ€å˜åŒ–](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315604)
- [GSE315492 PhillygeninæŠ‘åˆ¶ç»„è›‹ç™½ä¹³é…¸åŒ–ä¿®é¥°çš„NF-ÎºBï¼Œä»è€Œå‡è½»è„“æ¯’ç—‡å¼•èµ·çš„æ€¥æ€§è‚ºæŸä¼¤](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315492)
- [GSE300674 å¾®RNA-146aé€šè¿‡æŠ‘åˆ¶CCL5æ¥æŠµæŠ—è‚ç»†èƒç™Œ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300674)
- [GSE245850 çº¿ç²’ä½“å¤åˆç‰© I çš„åŸºå› æ‹¯æ•‘é€†è½¬äº†æ˜¼å¤œèŠ‚å¾‹çªå˜å°é¼ çš„ä»£è°¢ç¼ºé™·](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245850)
- [GSE315646 äººæºåŒ–å’Œç”µè·ä¼˜åŒ–çš„CSPG4ç‰¹å¼‚æ€§CAR-Tç»†èƒæ˜¾ç¤ºå‡ºå¯¹å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œçš„å¢å¼ºç–—æ•ˆ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315646)
- [GSE315628 å•ç»†èƒæ•°æ®å¯¹ FGFR3 é©±åŠ¨çš„åŸºå› è°ƒæ§ç½‘ç»œåˆ†ææ­ç¤ºäº† p63 åœ¨è…”å†…è†€èƒ±è‚¿ç˜¤ä¸­çš„ä¿ƒè‚¿ç˜¤ä½œç”¨](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315628)
- [GSE315569 é€‚ä½“ä¿®é¥°çš„5-æ°Ÿå°¿å˜§å•¶åŒ…å°é‡‘å±æœ‰æœºæ¡†æ¶çº³ç±³è¯ç‰©é€šè¿‡è¿‡æ°§åŒ–è¯±å¯¼ç»†èƒæ­»äº¡å¢å¼ºç»“ç›´è‚ ç™Œçš„æ²»ç–—](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315569)
- [GSE315365 TGF-Î²åˆºæ¿€çš„å°é¼ åŸä»£å¿ƒè„æˆçº¤ç»´ç»†èƒçš„è½¬å½•ç»„åˆ†æ](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315365)
- [GSE315188 æ¯•èµ¤é…µæ¯èŒæ ªè½¬å½•ç»„å­¦åˆ†æï¼Œè¿™äº›èŒæ ªç»åŸºå› å·¥ç¨‹æ”¹é€ åå¯æé«˜æ”¯é“¾æ°¨åŸºé…¸çš„äº§é‡](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315188)
- [GSE309688 åŠå…¬æ—¶é—´å†…çš„è‡ªç„¶å…‰ç…§å¯æ”¹å–„è¡€ç³–æ§åˆ¶å’Œå…¨èº«åº•ç‰©ä»£è°¢](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309688)
- [GSE308141 èƒšèƒè¡ç”Ÿè›‹ç™½ï¼ˆPDIã€CAPGã€PSAT1ï¼‰åœ¨æœ‰èƒç›˜å“ºä¹³åŠ¨ç‰©ä¸­é«˜åº¦ä¿å®ˆï¼Œå¹¶æ”¹å˜å­å®«å†…è†œä¸Šçš®ç»†èƒï¼ˆç‰›å’Œäººï¼‰çš„è½¬å½•ç»„](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308141)
- [GSE297796 è½¬åº§å…ƒä»¶å¢å¼ºè½¬å½•ç»„å¯å¡‘æ€§çš„åˆ¶å›¾å’Œæœºåˆ¶](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297796)
- [GSE287724 BRD2 è¿æ¥ TFIID å’Œç»„è›‹ç™½ä¹™é…°åŒ–åœ¨è½¬å½•èµ·å§‹ä¸­çš„ä½œç”¨ [PRO-Seq]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287724)
- [GSE286039 å¤šç»„å­¦å›¾è°±æ­ç¤ºç»†èƒæ¯’æ€§è¡¨å‹å’Œ ROS ç›¸å…³çš„ä»£è°¢é™æ­¢æ˜¯ CTL è€è¯ HIV æ„ŸæŸ“ CD4+ T ç»†èƒçš„å…³é”®ç‰¹å¾](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286039)
- [GSE285955 äº¤æ„Ÿç¥ç»æ”¯é…è°ƒèŠ‚éª¨éª¼è‚Œçš„ä»£è°¢å¯å¡‘æ€§](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285955)
- [GSE285787 DNAæŸä¼¤é©±åŠ¨æ¤ç‰©DNAç”²åŸºåŒ–çš„äº§ç”Ÿå’Œè¿›åŒ–](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285787)
- [GSE263042 scRNA-seq è¯„ä¼°æŠ— IL6R å’ŒæŠ— OSM åœ¨çº¤ç»´åŒ–è‚ºç—…æ¨¡å‹æ¶ˆé€€æœŸï¼ˆç¬¬ 24 å¤©ï¼‰çš„å½±å“ [NGS4659]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263042)
- [GSE263041 scRNA-seq è¯„ä¼°æŠ— IL6R å’ŒæŠ— OSM åœ¨çº¤ç»´åŒ–è‚ºç—…æ¨¡å‹ä¸­çº¤ç»´åŒ–æœŸé—´ï¼ˆç¬¬ 14 å¤©ï¼‰çš„å½±å“ [NGS4272]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263041)
- [GSE262966 ç¡®å®šæŠ—IL6å’ŒæŠ—OSMå¯¹çº¤ç»´åŒ–è‚ºç—…æ¨¡å‹ä¸­å·¨å™¬ç»†èƒå’Œæˆçº¤ç»´ç»†èƒç”Ÿç‰©å­¦çš„å½±å“[NGS3341]](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262966)

</div>

</details>

---

*ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-06 21:39*  
*ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ*